Tsuri Peretz

Title: Tsuri Peretz: Innovator in Cancer Treatment

Introduction

Tsuri Peretz is a notable inventor based in Kiryat Tivon, Israel. He has made significant contributions to the field of cancer treatment through his innovative research and development of monoclonal antibodies. With a total of 3 patents to his name, Peretz is recognized for his advancements in therapeutic methods.

Latest Patents

Among his latest patents, Tsuri Peretz has developed methods of use for anti-ILT2 antibodies. This invention provides monoclonal antibodies, or antigen-binding portions thereof, against ILT2, along with pharmaceutical compositions and methods for producing them. Additionally, it outlines methods for treating cancer by administering these antibodies or compositions. Another significant patent focuses on antibodies against ILT2 and their use, detailing similar pharmaceutical compositions and treatment methods for cancer, including patient selection strategies.

Career Highlights

Throughout his career, Tsuri Peretz has worked with various companies, including Biond Biologics Ltd. and Biond Biologies Ltd. His work has been instrumental in advancing cancer therapies and improving patient outcomes.

Collaborations

Tsuri has collaborated with notable colleagues such as Dana Haves Ziv and Ilana Goldshtein, contributing to a dynamic research environment that fosters innovation.

Conclusion

In summary, Tsuri Peretz is a distinguished inventor whose work in developing anti-ILT2 antibodies has the potential to transform cancer treatment. His contributions to the field are invaluable and continue to inspire future innovations.